Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/KCT0008093
KCT0008093Completed未知

Establishment of precision medicine platform for early diagnosis of mild cognitive impairment

Samsung Medical Center0 sites1,000 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
1,000
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational Study

Eligibility Criteria

Ages
45(Year) to 90(Year) (—)
Sex
All

Inclusion Criteria

  • •1. Adult men and women over the age of 45
  • •2. After listening to and fully understanding the detailed explanation of this study, the subject or legal representative voluntarily decides to participate in the study and gives written consent
  • •Subjective Cognitive Dysfunction (SCD)
  • •1. MMSE score above mean-1 SD when considering age, gender, and education level
  • •2. A willing and viable subject to cooperate with this study and complete all clinical trial stages
  • •Mild cognitive impairment (MCI)
  • •1. Patient or guardian complains of cognitive impairment
  • •2. Confirmation that cognitive ability including memory is lower than age and education through neuropsychological test (aMCI) Disorder (naMCI)
  • •3. Maintain overall cognitive function
  • •4. No disruption to daily life
  • •5. Dementia must not be determined by the clinician.
  • •Alzheimer's type dementia patients (AD)
  • •1. Probable AD dementia in the NIA-AA diagnostic guidelines for AD: Patients who satisfy the core clinical criteria and have an MMSE score of 10 or higher
  • •Frontotemporal dementia (FTD) dementia
  • •1. FTD includes bvFTD, nfvPPA, svPPA, according to their respective criteria.
  • •- bvFTD: according to the standard suggested by Bruce miller et al.
  • •- svPPA, nfvPPA : M.L. According to the criteria suggested by Gorno-Tempini et al.

Exclusion Criteria

  • •Exclusion from this study is required if one or more of the following conditions are met
  • •1) Patients with neurological abnormalities that may cause memory impairment on medical examination
  • •2) Those with a history of uniaxial psychiatric disorders including intellectual disability, schizophrenia, alcoholism, and bipolar disorder in the past
  • •3) Those with a history of malignant disease (cancer) within the last 3 years. Except for cervical carcinoma in situ or non-melanoma skin cancer.
  • •4) Those who have undergone cerebrovascular surgery, such as brain surgery or carotid artery surgery
  • •5) Those who have neurological symptoms that are evidence of cerebrovascular disease, such as extrapyramidal signs consistent with subcortical lesions.
  • •6) Those who have clear white matter on MRI. Distinctive white matter should conform to the following definition. Periventricular lesions measured in parallel with the ventricles should be 10 mm or more (extended cap) or an irregular edge and an irregular halo of more than 10 mm (irregular halo). change) or a local lesion, but more than an extensive deep white matter change.
  • •7) Those who have difficulty breathing when sitting still
  • •8) Those who have had memory impairment, speech impairment, or problem-solving ability for more than 2 hours after a heart attack
  • •9) Those who have been hospitalized for mental or emotional illness within the past 5 years
  • •10) Those with a history of drug abuse within the last 5 years
  • •11) Those with a history of treatment for alcoholism within the past 5 years
  • •12) Those who have lost consciousness for more than 1 hour due to causes other than general anesthesia
  • •13) Those who have been hospitalized with head injuries
  • •14) Those who cannot read normally even with glasses due to reduced vision
  • •15) Those who have difficulty understanding conversations due to hearing impairment even with hearing aids
  • •16) Pregnant and lactating women
  • •17) Other investigators who are judged inappropriate to participate in clinical trials

Investigators

Similar Trials

Recruiting
Not Applicable
Clinical and imaging biomarkers for predicting Parkinson's disease progressioDiseases of the nervous system
KCT0005552The Catholic University of Korea, Seoul St. Mary's Hospital1,000
Recruiting
Not Applicable
Establishment of clinical research platform based on dementia cohort
KCT0005516Samsung Medical Center300
Not yet recruiting
Not Applicable
Development of clinically high efficient platforms for individualised treatment of cervix cancer
CTRI/2021/08/035810Science and Engineering Research Board SERB
Not yet recruiting
Not Applicable
Construction of clinical data research platform for TCM dominant diseases of difficult diseasesSpondylosis
ITMCTR2000003815Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Not yet recruiting
Phase 1
To build a precise diagnosis and treatment system for membranous nephropathy based on the correlation between intestinal microecology and TCM tongue diagnosis
ITMCTR2000004026onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine